BioMarin Pharmaceutical, Inc. (BMRN)

55.27 +0.68 (+1.25%) USD  |  NASDAQ  |  Jan 20, 10:55
More

BioMarin Pharmaceutical Long Term Deferred Assets (Quarterly)

Long Term Deferred Assets (Quarterly) Chart

View Long Term Deferred Assets (Quarterly) for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Assets (Quarterly) Range, Past 5 Years

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Assets (Quarterly) Benchmarks

View Long Term Deferred Assets (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. --
Gilead Sciences, Inc. Upgrade
Merck & Co., Inc. --
AbbVie, Inc. --
Biogen, Inc. Upgrade